Bill Inman: drug safety physician and pharmacoepidemiologist.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2006 AND VI 29 AND IP 3
Results: 10
1
2
Extension of points on clarifying terminology in drug safety.
- Published in:
- 2006
- By:
- Publication type:
- commentary
3
Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan: An Observational Study.
- Published in:
- Drug Safety, 2006, v. 29, n. 3, p. 261, doi. 10.2165/00002018-200629030-00009
- By:
- Publication type:
- Article
4
Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up.
- Published in:
- 2006
- By:
- Publication type:
- journal article
5
Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis.
- Published in:
- 2006
- By:
- Publication type:
- journal article
6
Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.
- Published in:
- 2006
- By:
- Publication type:
- journal article
7
Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.
- Published in:
- 2006
- By:
- Publication type:
- journal article
8
The unknown impacts of combinations of large numbers of drugs.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
9
Safety and Tolerability of the Antibacterial Rifaximin in the Treatment of Travellers’ Diarrhoea.
- Published in:
- Drug Safety, 2006, v. 29, n. 3, p. 201, doi. 10.2165/00002018-200629030-00004
- By:
- Publication type:
- Article
10
A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration.
- Published in:
- 2006
- By:
- Publication type:
- journal article